Kangroo Mother Care

Preterm Birth Complication Clinical Trial

Official title:

Effect of Kangaroo Mother Care in Alleviating Preterm Infant's Pain

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05955404
• Other study ID #: kangroo mother care
• Status: Completed
• Phase: N/A
• Start date: November 2, 2022
• Est. completion date: February 28, 2023

Study information

• Verified date: July 2023
• Source: University of Baghdad
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

infants had a condition that might influence their responses to pain, e.g., congenital anomalies or severe illnesses requiring treatment with antiepileptics, muscle relaxants, or analgesic drugs.

Description:

infants had a condition that might influence their responses to pain, e.g., congenital anomalies or severe illnesses requiring treatment with antiepileptics, muscle relaxants, or analgesic drugs and comparing the pain intensity with preterm infants who receive conventional care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 21
• Est. completion date: February 28, 2023
• Est. primary completion date: February 28, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 32 Weeks to 37 Weeks

Eligibility

Inclusion Criteria:

• Preterm infants whose corrected gestational age from (32 - <37) weeks of pregnancy

• Preterm infants who do not experience any painful procedure for last 24 hours

• Preterm infants do not receive any sedation for last 24 hours

Exclusion Criteria:

• full-term infants whose corrected gestational age is >37 weeks

• extremely preterm (< 28 weeks)

• very preterm (28-<32 weeks)

• proven or suspected sepsis

• major congenital malformations

• all heart defect except neonatal Patent ductus arteriosus (PDA)

• necrotizing enterocolitis

• neurodevelopmental disability

• who receive respiratory support {Mechanical Ventilation, Continuous Positive Airway Pressure, or high-flow support

• indicated for surgery

• contraindication to oral sucrose

• Twins

• infants had a condition that might influence their responses to pain, e.g., congenital anomalies or severe illnesses requiring treatment with antiepileptics, muscle relaxants, or analgesic drugs

Related Conditions & MeSH terms

• Premature Birth
• Preterm Birth Complication

Intervention

Other:
• Kangaroo mother care
This study uses the Kangaroo mother care as a non-pharmacological strategy to alleviate the pain that preterm infants experience in the NICU.

Locations

Country	Name	City	State
Iraq	College of Nursing- The University of Baghdad	Baghdad

Sponsors (1)

Lead Sponsor	Collaborator
University of Baghdad

Country where clinical trial is conducted

Iraq, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Premature Infant Pain Profile-Revised (PIPP-R)	The Premature Infant Pain Profile-Revised (PIPP-R) measures the intensity of pain that the preterm infants experience in NICU through infant indicators (change in heart rate from baseline, decrease in oxygen saturation from baseline, browse bulge, eye squeeze, and naso-labial furrow. It also includes gestational age and behavioral state.	Two months